GREENLAND MINES LTD Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
GREENLAND MINES LTD (GRML) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $2.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-17
- GREENLAND MINES LTD cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was $2.83M, a 462.78% increase year-over-year.
- GREENLAND MINES LTD cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $502.13K, a 1600.51% increase year-over-year.
- GREENLAND MINES LTD cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $29.53K.
- GREENLAND MINES LTD cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$222.98K.
- GREENLAND MINES LTD cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $7.11M, a 11573.27% increase from fiscal 2024.
- GREENLAND MINES LTD cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $60.93K.
- GREENLAND MINES LTD cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$73.06K, a 121.74% decline from fiscal 2022.
- GREENLAND MINES LTD cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $336.01K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.17M 10-Q · filed 2026-08-17 | |||||
| 2026-03-31 | $2.83M 10-Q/A · filed 2026-08-14 | |||||
| 2025-12-31 | $7.11M 10-K/A · filed 2026-08-14 | |||||
| 2025-09-30 | $7.28M 10-Q · filed 2025-11-13 | |||||
| 2025-06-30 | $8.37M 10-Q · filed 2026-08-17 | |||||
| 2025-03-31 | $502.13K 10-Q/A · filed 2026-08-14 | |||||
| 2024-12-31 | $60.93K 10-K/A · filed 2026-08-14 | |||||
| 2024-09-30 | $48.09K 10-Q · filed 2025-11-13 | |||||
| 2024-06-30 | $842.53K 10-Q · filed 2025-08-18 | |||||
| 2024-03-31 | $29.53K 10-Q · filed 2025-05-15 | -$164.48K 10-Q · filed 2024-05-23 | ||||
| 2023-12-31 | -$73.06K 10-K · filed 2025-03-31 | -$168.43K 10-K · filed 2024-04-17 | ||||
| 2023-09-30 | -$73.73K 10-Q · filed 2024-11-19 | |||||
| 2023-06-30 | -$35.43K 10-Q · filed 2024-08-19 | |||||
| 2023-03-31 | -$222.98K 10-Q · filed 2024-05-23 | |||||
| 2022-12-31 | $336.01K 10-K · filed 2024-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |